Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer

Abstract

These findings suggest that inhibiting the Wnt/β-catenin pathway may have a potent immunomodulatory effect in the treatment of ovarian cancer, particularly when combined with paclitaxel.